ISCT is a global society of clinicians, regulators, technologists, and industry partners with a shared vision to translate cellular therapy into safe and effective therapies to improve patients’ lives. ISCT Members gain access to an influential global community of peers, experts, and organizations invested in cell therapy. ISCT offers a unique collaboration between academia, regulatory bodies, and industry partners in cell therapy translation.
Hear about the latest advances and future challenges in the development of efficacious cell-based therapies with learnings from the first allogeneic stem cell-based therapy approved by the European Medicines Agency for treatment of complex perianal fistulas in Crohn’s disease, mechanisms and results from several trials using CD34+ cell therapy for treatment of cardiovascular disease, and results of pre-clinical and IND enabling studies of MSC-based therapies for treating pediatric patients with cerebral palsy and autism
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.